RE:RE:RE:Blackhawk Submits SARS-CoV-2 IgG / IgM Rapid Test Kit The ExProbe SARS-CoV-2 TESTING KIT Interim order application has been progressing. On October 20 2020 we received a request for additional information from Health Canada. The information they were seeking involves 3 studies to be performed, given the complexity of the studies we requested until November 13, 2020 deadline to perform and submit the requested studies. The request was granted and we are confident that timeline will be met.
SARS-CoV-2 IgG / IgM Rapid Test Kit. The extensive application was submitted
November 4th and Health Canada confirmed receipt of the application the same day.
SARS-CoV-2 IgG / IgM Rapid Test Kit
currently holds Federal Drug Administration (FDA) Emergency Use Authorization (EUA)
as well as a CE Mark in Europe.